Content related to Children’s Hospital Los Angeles Treats First Patient on the West Coast Using Gene Therapy
‘A Rare Disease, But Not For Us’
August 23, 2019
It was obvious there was a problem as soon as Oliver was born. Oliver’s birth in 2015 was already complicated—he was in a breech position and had to be delivered via a cesarean section. But they
Oncoproteins Interact to Promote Cancer Cell Growth in Retinoblastoma
October 17, 2016
Microscopic image: MDM2 expression (in red) in retinoblastoma Rb176 cells. Credit: Donglai Qi, PhD, and David Cobrinik, MD, PhD. Researchers at The Saban Research Institute of Children’s Hospital Los
New cGMP Facility to Benefit Patient Care and Research
April 20, 2021
A state-of-the-art cell therapeutics facility will support the translation of novel cell therapy and tissue engineering approaches into clinical testing for a wide range of human diseases.
Precision Medicine for Pediatric Cancer
March 15, 2019
Research performed over the last several decades has led to an increased understanding of the genetics of cancer. The clinical application of this knowledge for pediatric cancer has lagged behind
Philanthropy Benefits All CHLA Patients
December 5, 2019
Every patient who visits Children’s Hospital Los Angeles benefits from generous philanthropists like the Anderson Stewart Family Foundation. Their contributions support the hospital’s leading-edge
A Series of Rare Heart Surgeries Saved Angelique Garcia
April 19, 2018
Even before Angelique Garcia was born, doctors at Children’s Hospital Los Angeles knew she had a severe form of congenital heart disease called complete atrioventricular canal defect (CAVC), thanks to
DNA Sequencing Uncovers Latent Risk for Developing Cystic Fibrosis
July 26, 2016
A study by researchers at Children’s Hospital Los Angeles (CHLA), Brigham and Women’s Hospital and the California Department of Public Health suggests that all babies with a known mutation for cystic
FDA approves new drug for Duchenne MD
September 30, 2016
The Food and Drug Administration has approved the first drug to treat patients with Duchenne muscular dystrophy, the most common muscular dystrophy diagnosed in childhood. Some experts contend that
Stay Up to Date
Sign up to receive our monthly newsletter, latest news, events and stories delivered right to your inbox.